• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例对联合化疗有反应的转移性乳腺外佩吉特病病例。

A case of metastatic extramammary Paget's disease that responded to combination chemotherapy.

作者信息

Yamazaki N, Yamamoto A, Wada T, Ishikawa M, Moriya Y, Nakanishi Y

机构信息

Dermatology Division, National Cancer Center Hospital, Tokyo, Japan.

出版信息

J Dermatol. 1999 May;26(5):311-6. doi: 10.1111/j.1346-8138.1999.tb03477.x.

DOI:10.1111/j.1346-8138.1999.tb03477.x
PMID:10380432
Abstract

Extramammary Paget's disease is considered to be a malignant tumor originating from the sweat glands. Some cases of extramammary Paget's disease infiltrate the dermis and metastasize to the regional lymph nodes. No standard treatment has been established for advanced cases. Few previous studies of the treatment for metastatic Paget's disease have revealed an effective regimen. The prognosis of metastasized cases is very poor. We encountered a patient in whom extramammary Paget's disease had metastasized to the lymph nodes beyond the regional lymph nodes and systemic chemotherapy was partially effective. Combination chemotherapy consisted of mitomycin C 3.5 mg/m2 and epirubicin 50 mg/m2 on day 1, vincristine 0.6 mg/m2 on days 1 and 7, cisplatin 30 mg/m2 from days 1 to 3, and 5-fluorouracil 350 mg/m2 from days 3 to 7. After two courses of chemotherapy, the metastatic lymph nodes decreased in size by more than 90% compared to that before chemotherapy. We defined the treatment effect of this regimen as a partial response (PR). Microscopic examination of the resected lymph nodes revealed replacement of metastatic lesions by fibrous tissue, suggesting a therapeutic effect. Anorexia, alopecia, and leukopenia (neutropenia) have been reported as toxicities, but all were tolerated. Our results may provide useful indications for the management of this tumor. This particular combination chemotherapy is recommended for extramammary Paget's disease patients with systemic nodal metastases.

摘要

乳腺外佩吉特病被认为是一种起源于汗腺的恶性肿瘤。部分乳腺外佩吉特病病例会浸润真皮并转移至区域淋巴结。对于晚期病例,尚未确立标准治疗方案。既往关于转移性佩吉特病治疗的研究很少揭示出有效的治疗方案。转移病例的预后非常差。我们遇到一名患者,其乳腺外佩吉特病已转移至区域淋巴结以外的淋巴结,全身化疗有部分疗效。联合化疗方案为第1天给予丝裂霉素C 3.5 mg/m²和表柔比星50 mg/m²,第1天和第7天给予长春新碱0.6 mg/m²,第1至3天给予顺铂30 mg/m²,第3至7天给予5-氟尿嘧啶350 mg/m²。两个化疗疗程后,转移淋巴结的大小较化疗前缩小了90%以上。我们将该方案的治疗效果定义为部分缓解(PR)。对切除淋巴结的显微镜检查显示转移性病变被纤维组织取代,提示有治疗效果。据报道,厌食、脱发和白细胞减少(中性粒细胞减少)为毒性反应,但所有这些反应患者均可耐受。我们的结果可能为该肿瘤的治疗提供有用的参考。对于有全身淋巴结转移的乳腺外佩吉特病患者,推荐使用这种特定的联合化疗方案。

相似文献

1
A case of metastatic extramammary Paget's disease that responded to combination chemotherapy.一例对联合化疗有反应的转移性乳腺外佩吉特病病例。
J Dermatol. 1999 May;26(5):311-6. doi: 10.1111/j.1346-8138.1999.tb03477.x.
2
Docetaxel induced durable response in advanced extramammary Paget's disease: a case report.多西他赛诱导晚期乳腺外佩吉特病产生持久反应:一例报告
J Dermatol. 2002 Jan;29(1):33-7. doi: 10.1111/j.1346-8138.2002.tb00162.x.
3
Trial of low-dose 5-fluorouracil/cisplatin therapy for advanced extramammary Paget's disease.低剂量5-氟尿嘧啶/顺铂治疗晚期乳房外佩吉特病的试验
Dermatol Surg. 2004 Feb;30(2 Pt 2):341-4. doi: 10.1111/j.1524-4725.2004.30093.x.
4
Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease.改良的顺铂、表阿霉素和紫杉醇每周方案在两例转移性乳腺外派杰氏病中诱导了持久的反应。
J Dermatol. 2017 Oct;44(10):1148-1151. doi: 10.1111/1346-8138.13869. Epub 2017 Apr 13.
5
[Chemotherapy for advanced adenocarcinoma of the skin: experience with combination chemotherapy and a review of the literature].[晚期皮肤腺癌的化疗:联合化疗经验及文献综述]
Gan To Kagaku Ryoho. 1997 Jan;24(1):30-6.
6
[Chemotherapy of advanced adenocarcinoma of the skin].[晚期皮肤腺癌的化疗]
Gan To Kagaku Ryoho. 1993 Aug;20(10):1302-7.
7
Extramammary Paget's disease/carcinoma successfully treated with a combination chemotherapy: report of two cases.联合化疗成功治疗乳腺外佩吉特病/癌:两例报告
J Dermatol. 2005 Aug;32(8):632-7. doi: 10.1111/j.1346-8138.2005.tb00812.x.
8
Metastatic extramammary Paget's disease: dramatic response to combined modality treatment.转移性乳腺外佩吉特病:对综合治疗的显著反应。
J Surg Oncol. 1988 May;38(1):38-44. doi: 10.1002/jso.2930380111.
9
Usefulness of sentinel lymph node biopsy for the detection of metastasis in the early stage of extramammary Paget's disease.前哨淋巴结活检在检测乳腺外佩吉特病早期转移中的应用价值
Eur J Dermatol. 2015 Apr;25(2):156-61. doi: 10.1684/ejd.2015.2534.
10
Efficacy of low-dose 5-fluorouracil/cisplatin therapy for invasive extramammary Paget's disease.低剂量 5-氟尿嘧啶/顺铂治疗侵袭性乳腺外派杰氏病的疗效。
J Dermatol. 2018 May;45(5):560-563. doi: 10.1111/1346-8138.14247. Epub 2018 Feb 14.

引用本文的文献

1
Primary perianal Paget's disease: three cases.原发性肛周佩吉特病:三例报告
J Surg Case Rep. 2023 Dec 28;2023(12):rjad684. doi: 10.1093/jscr/rjad684. eCollection 2023 Dec.
2
Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity.乳腺外佩吉特病:一种罕见疾病的治疗挑战
Curr Oncol Rep. 2023 Oct;25(10):1081-1094. doi: 10.1007/s11912-023-01434-0. Epub 2023 Jul 8.
3
Current Management and Treatment of Extramammary Paget's Disease.目前对派杰氏病的治疗和管理。
Curr Treat Options Oncol. 2022 Jun;23(6):818-830. doi: 10.1007/s11864-021-00923-3. Epub 2022 Apr 4.
4
The Outcome of Chemotherapy for Metastatic Extramammary Paget's Disease.转移性乳腺外佩吉特病的化疗结果
J Clin Med. 2021 Feb 12;10(4):739. doi: 10.3390/jcm10040739.
5
Combination chemotherapy of low-dose 5-fluorouracil and cisplatin for advanced extramammary Paget's disease.低剂量5-氟尿嘧啶和顺铂联合化疗治疗晚期乳房外佩吉特病
Int J Clin Oncol. 2015 Feb;20(1):194-7. doi: 10.1007/s10147-014-0686-2. Epub 2014 Apr 2.
6
Management of penoscrotal extramammary Paget disease: case series and review of the literature.阴茎阴囊部外佩吉特病的治疗:病例系列和文献复习。
Curr Oncol. 2013 Aug;20(4):e311-20. doi: 10.3747/co.20.1353.
7
Response to 5-fluorouracil in metastatic extramammary Paget disease of the scrotum presenting as pancytopenia and back pain.转移性阴囊外 Paget 病出现全血细胞减少和背痛对氟尿嘧啶的反应。
Curr Oncol. 2009 Sep;16(5):81-3. doi: 10.3747/co.v16i5.374.